Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
475.3 USD | +0.34% | -1.60% | +16.45% |
17/06 | Argus Adjusts Price Target on Vertex Pharmaceuticals to $550 From $465 | MT |
14/06 | Vertex Pharmaceuticals Says Gene-Editing Therapy Demonstrates Clinical Benefits in Genetic Disease Trials | MT |